Latest KFF Health News Content

Latest KFF Health News Stories

Federal Spending Grew Even As DOGE Axed Agencies, Culled Health Sector

Morning Briefing

According to the nonpartisan Penn Wharton Budget Model, which tracks weekly Treasury data, total spending rose by 6.3%, or $156 billion, since Donald Trump took office, compared to the first four months of 2024, Politico reported.

Supreme Court Sides With HHS Over Medicare Reimbursement Calculation

Morning Briefing

Roll Call reports that the 7-2 decision rejects an effort by hospitals for higher pay for serving low-income patients. Other Medicare and Medicaid news is on prior authorizations, Medicaid cuts, and more.

With Congress’ Approval, Bill Banning Revenge Porn Is Sent To The President

Morning Briefing

The Take It Down Act would make it a crime to post real or AI-generated intimate images or videos online without the subject’s consent and would require platforms to remove the items. President Trump is expected to sign the bipartisan measure, which has the support of leading tech companies.

Researchers Find That 1 Dose Of HPV Vaccine Is Just As Effective As 2

Morning Briefing

The data, which suggest that one shot helps prevent cancer, came from a clinical trial run by the National Cancer Institute. Also in vaccine news: a tuberculosis vaccine trial; vaccine policy at the FDA; and more.

Third-Party Data Breach Hits Ascension Health Patients In 5 States

Morning Briefing

Ascension announced Monday that a former vendor who had access to patients’ information was hacked, potentially exposing the health data of people in Alabama, Michigan, Indiana, Tennessee, and Texas. Separately, health insurer Blue Cross and Blue Shield of Illinois has suffered a data breach.

Law Requiring Parents Be Notified Of Minors’ Abortions Blocked In Nevada

Morning Briefing

The law was set to be reinstated Wednesday but has been temporarily blocked by U.S. District Judge Anne Traum to allow Planned Parenthood time to challenge it. They have until Friday to file an appeal.

7.2 Million Americans Now Suffer With Alzheimer’s

Morning Briefing

This is an increase of 300,000 cases from a year ago. At the same time, NIH funding cuts will stall research and harm Alzheimer’s patients, USA TODAY reported. In other Alzheimer’s news, improved diagnostic testing has up to 91% accuracy; new research shows it’s common for patients with Alzheimer’s to also have biomarkers for dementia; and more.

Changes At CFPB May Upend Efforts To Ban Medical Debt From Credit Reports

Morning Briefing

For now, an effort to lay off nearly all Consumer Financial Protection Bureau employees is on hold. But if the agency is shuttered, a Biden-era rule that would prevent credit agencies from including medical debt on credit reports would likely be overturned or wither away, The Washington Post says.

Eugene, Oregon’s Trailblazing ‘Cahoots’ Mobile Crisis Unit Has Been Disbanded

Morning Briefing

The city’s effort was hailed as a national model for other cities and inspired the Cahoots Act in the 2021 stimulus bill, which increased funding for mobile crisis units, The Wall Street Journal reported. A small team remains in nearby Springfield, Oregon.

Many Drug Addiction Programs Will Be Discontinued, HHS Draft Budget Says

Morning Briefing

The New York Times reported that grants to provide and train first responders to administer the overdose-reversal nasal spray Narcan would be eliminated, as could treatment initiatives for pregnant and postpartum women.

Food Banks Struggle To Feed The Needy After Trump Cuts Federal Aid

Morning Briefing

The national advocacy group Feeding America reports that the Trump administration slashed $1 billion in federal aid to anti-hunger groups. In other nutrition news, links have been found between ultra-processed food consumption and premature death; finding replacements for artificial food dyes leads to interesting sources; and more.

After Covid Vaccine Delay, Makary Infers Other Shots Need More Scrutiny

Morning Briefing

The FDA, which was supposed to decide by April 1 whether it would approve Novavax’s application for a full license, is seeking more clinical studies of the vaccine. Now, because other drugmakers update shots every year, the agency might have them conduct regulatory studies as well, FDA chief Marty Makary suggested.